PRDA Stock Overview
PT Prodia Widyahusada Tbk provides clinical laboratory services primarily in Indonesia.
| Snowflake Score | |
|---|---|
| Valuation | 6/6 |
| Future Growth | 1/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
PT Prodia Widyahusada Tbk Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | Rp3,470.00 |
| 52 Week High | Rp6,800.00 |
| 52 Week Low | Rp3,410.00 |
| Beta | 0.096 |
| 1 Month Change | -13.90% |
| 3 Month Change | -33.27% |
| 1 Year Change | -41.19% |
| 3 Year Change | -11.25% |
| 5 Year Change | 20.91% |
| Change since IPO | -47.42% |
Recent News & Updates
Recent updates
Shareholder Returns
| PRDA | ID Healthcare | ID Market | |
|---|---|---|---|
| 7D | -10.3% | -1.6% | -1.4% |
| 1Y | -41.2% | 0.8% | 2.2% |
Return vs Industry: PRDA underperformed the ID Healthcare industry which returned 0.8% over the past year.
Return vs Market: PRDA underperformed the ID Market which returned 2.2% over the past year.
Price Volatility
| PRDA volatility | |
|---|---|
| PRDA Average Weekly Movement | 3.2% |
| Healthcare Industry Average Movement | 4.7% |
| Market Average Movement | 5.1% |
| 10% most volatile stocks in ID Market | 12.0% |
| 10% least volatile stocks in ID Market | 2.3% |
Stable Share Price: PRDA's share price has been volatile over the past 3 months.
Volatility Over Time: PRDA's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1973 | 2,958 | Dewi Muliaty | prodia.co.id/id |
PT Prodia Widyahusada Tbk provides clinical laboratory services primarily in Indonesia. The company offers laboratory, genomic, non-laboratory, and panel test services. It also operates Prodia health care and specialty clinics; and offers vaccination services.
PT Prodia Widyahusada Tbk Fundamentals Summary
| PRDA fundamental statistics | |
|---|---|
| Market cap | Rp3.25t |
| Earnings (TTM) | Rp259.87b |
| Revenue (TTM) | Rp2.22t |
12.5x
P/E Ratio1.5x
P/S RatioIs PRDA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PRDA income statement (TTM) | |
|---|---|
| Revenue | Rp2.22t |
| Cost of Revenue | Rp957.10b |
| Gross Profit | Rp1.27t |
| Other Expenses | Rp1.01t |
| Earnings | Rp259.87b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 277.20 |
| Gross Margin | 56.94% |
| Net Profit Margin | 11.69% |
| Debt/Equity Ratio | 0.2% |
How did PRDA perform over the long term?
See historical performance and comparison